Evidence map›Paper›PMID 42733743›Full record

ArticleJournal of molecular and cellular cardiology plus2026

Heterogeneous nuclear ribonucleoprotein A1 as a candidate associated with pulmonary vascular remodeling in pulmonary arterial hypertension.

Yoshihito Morimoto, Yoshiaki Sato, Katsuhiro Kato, Hidenori Yamamoto, Kentaro Suzuki, Kiyotaka Go, Yoshie Fukasawa, Naoki Ohashi, Yoshiyuki Takahashi, Taichi Kato

Abstract read
In one paragraph

Article in Journal of molecular and cellular cardiology plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yoshihito MorimotoDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Yoshiaki SatoDivision of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Aichi, Japan.
Katsuhiro KatoDepartment of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Hidenori YamamotoDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Kentaro SuzukiDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Kiyotaka GoDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Yoshie FukasawaDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Naoki OhashiDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Yoshiyuki TakahashiDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Taichi KatoDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale: Although plexiform lesion (PL) formation in severe pulmonary arterial hypertension (PAH) is a therapeutic target, the mechanisms underlying their formation have not been fully elucidated. Objective: To identify candidate proteins involved in PL formation by examining differentially expressed proteins (DEPs) in PAH lesions. Methods: Proteomic remodeling was assessed before and after the formation of PLs in a SU5416 combined with hypoxia (SuHx) rat model of severe PAH using laser-capture microdissection coupled with mass spectrometry. Unobstructed pulmonary arteries with medial hypertrophy (UMHPAs) and PLs from SuHx rats were subjected to qualitative and quantitative proteomics, revealing DEPs between these structures. Results: We identified 718 proteins with 58 DEPs, of which 31 were upregulated in UMHPAs and 27 were upregulated in PLs. Immunostaining confirmed that DEPs detected in our proteomic analysis were differentially expressed between UMHPAs and PLs. Among them, we focused on heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) as a candidate protein that may be associated with PL formation because of its strong association with cell proliferation. Small interfering RNA knockdown of hnRNPA1 in hypoxia-treated pulmonary artery smooth muscle cells reduced pyruvate kinase M2 expression and decreased proliferative capacity. Conclusions: Several DEPs associated with PL formation but with unclear relevance to pulmonary artery remodeling in PAH were discovered. Among these, hnRNPA1, which was not detected in transcriptome analysis and whole lung analysis, may be important in PL formation.

Indexed as

Differentially expressed proteinsPlexiform lesion formationRat modelUnobstructed pulmonary arteries with medial hypertrophy

Identifiers

PMID42733743
PMCPMC13571748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.